Search Results 1-10 of 28000 for ������������������,������������������������������������13984852298
Mayo Clinic researcher Keith M. Furutani, Ph.D., studies emerging technologies in radiation therapy, especially carbon ion radiation therapy.
Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...
The candidate must be able to learn to perform visual and tactile examinations to differentiate subtle variations in color, shape and general appearance.
About this study. VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study.
About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of ...
Description. The Family Medicine elective is a subinternship that consists of two components and is designed to involve the fourth-year medical student as a ...
The primary purpose of this study is to evaluate the long-term safety and tolerability of LIQ861, a dry powder formulation of treprostinil, in patients with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.